TapewireFind a company

organization · Reporting owner

REGENTS OF THE UNIVERSITY OF CALIFORNIA

Disclosed activity across 2 companies

Tapewire entity
99125
SEC CIK
0000315054

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Blue Owl Capital Corp

Report date June 16, 2021 · Filed June 17, 2021

Section 16 reporting ended · disclosed 2021-06-17. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect39,139,093 Reported balance After 2021-06-16 transaction · row 1
1 source row

Row 1 · 2021-06-16 · Sale · Disposed 124,437 · Balance 39,139,093

F1: The price is a weighted average of the multiple trades that took place on 6/16/2021. The lowest price at which the shares were sold was $14.80 and the highest price was $14.97.

Filing footnotes · ownership attribution and instrument terms

F1: The price is a weighted average of the multiple trades that took place on 6/16/2021. The lowest price at which the shares were sold was $14.80 and the highest price was $14.97.

CONSTELLATION PHARMACEUTICALS INC

Report date November 08, 2019 · Filed November 14, 2019 · Amendment

Section 16 reporting ended · disclosed 2019-11-14. Current position is not established by this disclosure.

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect2,197,406 Reported balance After 2019-11-08 transaction · row 1 Amendment: may correct only part of an earlier disclosure.
1 source row

Row 1 · 2019-11-08 · Sale · Disposed 100,000 · Balance 2,197,406

F1: Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D).

Common StockSEC Table I · non-derivativeDirect2,123,090 Reported balance After 2019-11-08 transaction · row 2 Amendment: may correct only part of an earlier disclosure.
1 source row

Row 2 · 2019-11-08 · Sale · Disposed 74,316 · Balance 2,123,090

F2: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090.

Common StockSEC Table I · non-derivativeDirect2,110,290 Reported balance After 2019-11-12 transaction · row 3 Amendment: may correct only part of an earlier disclosure.
1 source row

Row 3 · 2019-11-12 · Sale · Disposed 12,800 · Balance 2,110,290

F3: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290.

Filing footnotes · ownership attribution and instrument terms

F1: Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D).

F2: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090.

F3: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 03, 2020 Filed Jun 4, 2020 01:07 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 39,250 $12.78 $501,732.75
Disclosure

SEC source: 0001140361-20-013006 · form4.xml · nonDerivative · entry 2

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,047,303

F2 · price: The price is a weighted average of the multiple trades that took place on 6/3/2020. The lowest price at which the shares were sold was $12.70 and the highest price was $12.96.

Read SEC document
June 02, 2020 Filed Jun 4, 2020 01:07 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 7,200 $12.74 $91,735.20
Disclosure

SEC source: 0001140361-20-013006 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,086,553

F1 · price: The price is a weighted average of the multiple trades that took place on 6/2/2020. The lowest price at which the shares were sold was $12.70 and the highest price was $12.77.

Read SEC document
May 28, 2020 Filed May 29, 2020 01:02 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 120,572 $12.83 $1,546,818.19
Disclosure

SEC source: 0001140361-20-012640 · form4.xml · nonDerivative · entry 2

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,093,753

F2 · price: The price is a weighted average of the multiple trades that took place on 5/28/2020. The lowest price at which the shares were sold was $12.70 and the highest price was $12.99.

Read SEC document
May 27, 2020 Filed May 29, 2020 01:02 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 35,897 $12.71 $456,143.18
Disclosure

SEC source: 0001140361-20-012640 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,214,325

F1 · price: The price is a weighted average of the multiple trades that took place on 5/27/2020. The lowest price at which the shares were sold was $12.70 and the highest price was $12.73.

Read SEC document
May 21, 2020 Filed May 21, 2020 22:01 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 52,742 $12.66 $667,871.95
Disclosure

SEC source: 0001140361-20-012222 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,250,222

F1 · price: The price is a weighted average of the multiple trades that took place on 5/21/2020. The lowest price at which the shares were sold was $12.57 and the highest price was $12.71.

Read SEC document
May 20, 2020 Filed May 21, 2020 00:15 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 43,149 $12.69 $547,517.66
Disclosure

SEC source: 0001140361-20-012092 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,302,964

F1 · price: The price is a weighted average of the multiple trades that took place on 5/20/2020. The lowest price at which the shares were sold was $12.62 and the highest price was $12.83.

Read SEC document
May 19, 2020 Filed May 19, 2020 23:33 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 49,370 $12.64 $624,086.17
Disclosure

SEC source: 0001140361-20-011982 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,346,113

F1 · price: The price is a weighted average of the multiple trades that took place on 5/19/2020. The lowest price at which the shares were sold was $12.54 and the highest price was $12.75.

Read SEC document
May 11, 2020 Filed May 12, 2020 00:48 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 145,000 $12.58 $1,823,665.00
Disclosure

SEC source: 0001140361-20-011342 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,395,483

F1 · price: The price is a weighted average of the multiple trades that took place on 5/11/2020. The lowest price at which the shares were sold was $12.50 and the highest price was $12.685.

Read SEC document
May 08, 2020 Filed May 9, 2020 00:07 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 145,000 $13.06 $1,894,135.00
Disclosure

SEC source: 0001140361-20-011168 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,540,483

F1 · price: The price is a weighted average of the multiple trades that took place on 5/8/2020. The lowest price at which the shares were sold was $12.61 and the highest price was $13.38.

Read SEC document
May 07, 2020 Filed May 8, 2020 18:13 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 143,000 $13.15 $1,880,164.00
Disclosure

SEC source: 0001140361-20-011069 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,685,483

F1 · price: The price is a weighted average of the multiple trades that took place on 5/7/2020. The lowest price at which the shares were sold was $13.00 and the highest price was $13.36.

Read SEC document
May 05, 2020 Filed May 7, 2020 00:06 UTC Blue Owl Capital Corp ORCC · Entity 3829 SaleCommon Stock 131,878 $12.61 $1,662,585.95
Disclosure

SEC source: 0001140361-20-010882 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,828,483

F1 · price: The price is a weighted average of the multiple trades that took place on 5/5/2020. The lowest price at which the shares were sold was $12.50 and the highest price was $12.77.

Read SEC document
November 12, 2019 Filed Nov 13, 2019 02:19 UTC CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 SaleCommon Stock 12,800 $32.77 $419,456.00
Disclosure

SEC source: 0001140361-19-020387 · form4.xml · nonDerivative · entry 3

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,111,290

Read SEC document
November 12, 2019 Filed Nov 14, 2019 01:31 UTC Amendment CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 SaleCommon Stock 12,800 $32.77 $419,456.00
Disclosure

SEC source: 0001140361-19-020486 · form4.xml · nonDerivative · entry 3

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,110,290

F3 · acquired: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290.

F3 · balance_after: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290.

Read SEC document
November 08, 2019 Filed Nov 13, 2019 02:19 UTC CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 SaleCommon Stock 74,316 $30.44 $2,262,179.04
Disclosure

SEC source: 0001140361-19-020387 · form4.xml · nonDerivative · entry 2

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,127,090

Read SEC document
November 08, 2019 Filed Nov 13, 2019 02:19 UTC CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 SaleCommon Stock 1,000,000 $30.25 $30,250,000.00
Disclosure

SEC source: 0001140361-19-020387 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,197,406

Read SEC document
November 08, 2019 Filed Nov 14, 2019 01:31 UTC Amendment CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 SaleCommon Stock 74,316 $30.44 $2,262,179.04
Disclosure

SEC source: 0001140361-19-020486 · form4.xml · nonDerivative · entry 2

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,123,090

F2 · acquired: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090.

F2 · balance_after: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090.

Read SEC document
November 08, 2019 Filed Nov 14, 2019 01:31 UTC Amendment CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 SaleCommon Stock 100,000 $30.25 $3,025,000.00
Disclosure

SEC source: 0001140361-19-020486 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,197,406

F1 · shares: Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D).

F1 · acquired: Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D).

Read SEC document
June 17, 2019 Filed Apr 30, 2020 00:15 UTC Blue Owl Capital Corp ORCC · Entity 3829 OtherCommon Stock 9,463,962.126 $15.27 $144,514,701.66
Disclosure

SEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 6

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,960,361

F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call.

F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program.

Read SEC document
March 21, 2019 Filed Apr 30, 2020 00:15 UTC Blue Owl Capital Corp ORCC · Entity 3829 OtherCommon Stock 1,761,102.751 $15.57 $27,420,369.83
Disclosure

SEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 5

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,082,153.509

F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call.

F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program.

Read SEC document
February 12, 2019 Filed Apr 30, 2020 00:15 UTC Blue Owl Capital Corp ORCC · Entity 3829 OtherCommon Stock 2,670,815.092 $15.40 $41,130,552.42
Disclosure

SEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 4

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,321,050.758

F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call.

F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program.

Read SEC document
December 11, 2018 Filed Apr 30, 2020 00:15 UTC Blue Owl Capital Corp ORCC · Entity 3829 OtherCommon Stock 2,051,655.083 $15.59 $31,985,302.74
Disclosure

SEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 3

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,025,638.193

F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call.

F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program.

Read SEC document
October 04, 2018 Filed Apr 30, 2020 00:15 UTC Blue Owl Capital Corp ORCC · Entity 3829 OtherCommon Stock 895,946.698 $15.30 $13,707,984.48
Disclosure

SEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 2

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,399,193.256

F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call.

F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program.

Read SEC document
August 20, 2018 Filed Apr 30, 2020 00:15 UTC Blue Owl Capital Corp ORCC · Entity 3829 OtherCommon Stock 1,838,403.42 $15.46 $28,421,716.87
Disclosure

SEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,503,246.558

F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call.

F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program.

Read SEC document
August 06, 2018 Filed Aug 9, 2018 01:23 UTC Blue Owl Capital Corp NONE · Entity 3829 PurchaseCommon Stock 2,533,043.227 $15.41 $39,034,196.13
Disclosure

SEC source: 0001567619-18-000171 · doc1.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,271,511.912

Read SEC document
July 23, 2018 Filed Jul 24, 2018 00:15 UTC CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 ConversionSeries F Preferred Stock · Derivative 8,750,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-020458 · doc4.xml · derivative · entry 5

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 794,806 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

F1 · derivative.exercise_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

F1 · derivative.expiration_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

Read SEC document
July 23, 2018 Filed Jul 24, 2018 00:15 UTC CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 ConversionSeries E-1 Preferred Stock · Derivative 6,502,856 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-020458 · doc4.xml · derivative · entry 4

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 590,684 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

F1 · derivative.exercise_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

F1 · derivative.expiration_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

Read SEC document
July 23, 2018 Filed Jul 24, 2018 00:15 UTC CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 ConversionSeries E Preferred Stock · Derivative 6,666,666 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-020458 · doc4.xml · derivative · entry 3

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 778,583 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

F1 · derivative.exercise_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

F1 · derivative.expiration_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

Read SEC document
July 23, 2018 Filed Jul 24, 2018 00:15 UTC CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 PurchaseCommon Stock 133,333 $15.00 $1,999,995.00
Disclosure

SEC source: 0000899243-18-020458 · doc4.xml · nonDerivative · entry 2

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,297,406

Read SEC document
July 23, 2018 Filed Jul 24, 2018 00:15 UTC CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 ConversionCommon Stock 2,164,073 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-18-020458 · doc4.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,164,073

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

Read SEC document
June 27, 2018 Filed Jul 2, 2018 20:53 UTC Blue Owl Capital Corp NONE · Entity 3829 PurchaseCommon Stock 2,882,149.88 $15.50 $44,673,323.14
Disclosure

SEC source: 0001140361-18-030928 · doc1.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,738,468.685

Read SEC document
June 09, 2017 Filed Jun 12, 2017 21:10 UTC Blue Owl Capital Corp NONE · Entity 3829 PurchaseCommon Stock 2,603,538.459 $15.05 $39,183,253.81
Disclosure

SEC source: 0001140361-17-024717 · doc1.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,856,318.805

Read SEC document
May 24, 2017 Filed May 30, 2017 20:14 UTC Blue Owl Capital Corp NONE · Entity 3829 PurchaseCommon Stock 1,632,765.346 $14.97 $24,442,497.23
Disclosure

SEC source: 0001140361-17-022815 · doc1.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,252,780.346

Read SEC document
April 17, 2017 Filed Apr 19, 2017 17:42 UTC Blue Owl Capital Corp NONE · Entity 3829 PurchaseCommon Stock 4,500,000 $15.09 $67,905,000.00
Disclosure

SEC source: 0001140361-17-016153 · doc1.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,620,015

Read SEC document
December 27, 2016 Filed Dec 30, 2016 17:19 UTC Blue Owl Capital Corp NONE · Entity 3829 PurchaseCommon Stock 4,301,443 $14.86 $63,919,442.98
Disclosure

SEC source: 0001140361-16-091167 · doc1.xml · nonDerivative · entry 1

REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,120,015

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.